Merck & Company, Inc. - Payout Ratio History
Payout ratio history for stock MRK (Merck & Company, Inc.).
| Date | Payout ratio |
|---|---|
| April 2024 | 171.11% |
| March 2024 | 171.11% |
| February 2024 | 171.11% |
| January 2024 | 36.15% |
| December 2023 | 34.27% |
| November 2023 | 36.92% |
| October 2023 | 36.73% |
| September 2023 | 37.53% |
| August 2023 | 34.35% |
| July 2023 | 34.31% |
| June 2023 | 34.23% |
| May 2023 | 34.31% |
| April 2023 | 34.31% |
| March 2023 | 34.19% |
| February 2023 | 39.46% |
| January 2023 | 38.68% |
| December 2022 | 38.68% |
| November 2022 | 36.90% |
| October 2022 | 38.07% |
| September 2022 | 38.07% |
| August 2022 | 38.33% |
| July 2022 | 41.32% |
| June 2022 | 41.32% |
| May 2022 | 41.32% |
| April 2022 | 41.32% |
| March 2022 | 41.32% |
| February 2022 | 41.32% |
| January 2022 | 41.32% |
| December 2021 | 38.92% |
| October 2021 | 122.64% |
| September 2021 | 122.64% |
| August 2021 | 98.48% |
| July 2021 | 98.48% |
| June 2021 | 93.86% |
| May 2021 | 93.53% |
| April 2021 | 93.53% |
| March 2021 | 93.53% |
| February 2021 | 57.40% |
| January 2021 | 63.41% |
| December 2020 | 53.66% |
| November 2020 | 53.36% |
| October 2020 | 53.36% |
| September 2020 | 53.36% |
| August 2020 | 55.34% |
| July 2020 | 55.34% |
| June 2020 | 55.34% |
| May 2020 | 94.83% |
| April 2020 | 94.83% |
| March 2020 | 94.83% |
| February 2020 | 94.83% |
| January 2020 | 94.83% |
| December 2019 | 94.83% |
| November 2019 | 94.83% |
| October 2019 | 94.83% |
| September 2019 | 94.83% |
| August 2019 | 94.83% |
| July 2019 | 94.83% |
| June 2019 | 94.83% |
| May 2019 | 94.83% |
| April 2019 | 94.83% |
| March 2019 | 94.83% |
| February 2019 | 94.83% |
| December 2018 | 153.60% |
| December 2017 | 180.80% |
| December 2016 | 93.80% |
| December 2015 | 48.40% |
| December 2014 | 95.70% |
| December 2013 | 115.40% |
| December 2012 | 84.50% |
| December 2011 | 110.90% |
| December 2010 | 542.90% |
| December 2009 | 26.90% |
| December 2008 | 41.80% |
| December 2007 | 100.82% |
| December 2006 | 59.77% |
| December 2005 | 59.48% |
| December 2004 | 57.75% |
| December 2003 | 51.25% |
| December 2002 | 46.47% |
| December 2001 | 44.44% |
| December 2000 | 47.36% |
| December 1999 | 53.24% |
MRK
List: Contenders
Price: $126.78
Dividend Yield: 0.02%
Forward Dividend Yield: 2.43%
Payout Ratio: 171.11%
Dividend Per Share: 3.08 USD
Earnings Per Share: 0.14 USD
P/E Ratio: 70.23
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 7.8 million
Ebitda: 2.3 billionMarket Capitalization: 320.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 63
DGR3: 8.71%
DGR5: 9.43%
DGR10: 5.84%
DGR20: 10.47%